These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 8855818)

  • 21. Interrelationships among lipoprotein levels, sex hormones, anthropometric parameters, and age in hypogonadal men treated for 1 year with a permeation-enhanced testosterone transdermal system.
    Dobs AS; Bachorik PS; Arver S; Meikle AW; Sanders SW; Caramelli KE; Mazer NA
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1026-33. PubMed ID: 11238481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone therapy preserves muscle strength and power in aging men with type 2 diabetes-a randomized controlled trial.
    Magnussen LV; Hvid LG; Hermann AP; Hougaard DM; Gram B; Caserotti P; Andersen MS
    Andrology; 2017 Sep; 5(5):946-953. PubMed ID: 28914503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delta-4-androstene-3,17-dione binds androgen receptor, promotes myogenesis in vitro, and increases serum testosterone levels, fat-free mass, and muscle strength in hypogonadal men.
    Jasuja R; Ramaraj P; Mac RP; Singh AB; Storer TW; Artaza J; Miller A; Singh R; Taylor WE; Lee ML; Davidson T; Sinha-Hikim I; Gonzalez-Cadavid N; Bhasin S
    J Clin Endocrinol Metab; 2005 Feb; 90(2):855-63. PubMed ID: 15522925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sublingual administration of testosterone-hydroxypropyl-beta-cyclodextrin inclusion complex simulates episodic androgen release in hypogonadal men.
    Stuenkel CA; Dudley RE; Yen SS
    J Clin Endocrinol Metab; 1991 May; 72(5):1054-9. PubMed ID: 1902483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men.
    Zhang GY; Gu YQ; Wang XH; Cui YG; Bremner WJ
    J Androl; 1998; 19(6):761-8. PubMed ID: 9876028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteopenia in eugonadal men with acquired immune deficiency syndrome wasting syndrome.
    Fairfield WP; Finkelstein JS; Klibanski A; Grinspoon SK
    J Clin Endocrinol Metab; 2001 May; 86(5):2020-6. PubMed ID: 11344201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of micronized progesterone on bone turnover in postmenopausal women on estrogen replacement therapy.
    Azizi G; Hansen A; Prestwood KM
    Endocr Res; 2003 May; 29(2):133-40. PubMed ID: 12856800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen supplementation in eugonadal men with osteoporosis: effects of six months' treatment on markers of bone formation and resorption.
    Anderson FH; Francis RM; Peaston RT; Wastell HJ
    J Bone Miner Res; 1997 Mar; 12(3):472-8. PubMed ID: 9076591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis.
    Isidori AM; Giannetta E; Greco EA; Gianfrilli D; Bonifacio V; Isidori A; Lenzi A; Fabbri A
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):280-93. PubMed ID: 16117815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A small-scale clinical trial to determine the safety and efficacy of testosterone replacement therapy in hypogonadal men with spinal cord injury.
    Bauman WA; Cirnigliaro CM; La Fountaine MF; Jensen AM; Wecht JM; Kirshblum SC; Spungen AM
    Horm Metab Res; 2011 Jul; 43(8):574-9. PubMed ID: 21717386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bone mineral density, body composition and bone turnover in patients with congenital hypogonadotropic hypogonadism.
    Laitinen EM; Hero M; Vaaralahti K; Tommiska J; Raivio T
    Int J Androl; 2012 Aug; 35(4):534-40. PubMed ID: 22248317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single and combined effects of growth hormone and testosterone administration on measures of body composition, physical performance, mood, sexual function, bone turnover, and muscle gene expression in healthy older men.
    Brill KT; Weltman AL; Gentili A; Patrie JT; Fryburg DA; Hanks JB; Urban RJ; Veldhuis JD
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5649-57. PubMed ID: 12466367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels.
    Kenny AM; Prestwood KM; Gruman CA; Marcello KM; Raisz LG
    J Gerontol A Biol Sci Med Sci; 2001 May; 56(5):M266-72. PubMed ID: 11320105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sildenafil improves sleep-related erections in hypogonadal men: evidence from a randomized, placebo-controlled, crossover study of a synergic role for both testosterone and sildenafil on penile erections.
    Rochira V; Balestrieri A; Madeo B; Granata AR; Carani C
    J Androl; 2006; 27(2):165-75. PubMed ID: 16278367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sublingual administration of micronized estradiol and progesterone, with and without micronized testosterone: effect on biochemical markers of bone metabolism and bone mineral density.
    Miller BE; De Souza MJ; Slade K; Luciano AA
    Menopause; 2000; 7(5):318-26. PubMed ID: 10993031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men.
    van den Beld AW; de Jong FH; Grobbee DE; Pols HA; Lamberts SW
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3276-82. PubMed ID: 10999822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transdermal androgen therapy to augment EPO in the treatment of anemia of chronic renal disease.
    Brockenbrough AT; Dittrich MO; Page ST; Smith T; Stivelman JC; Bremner WJ
    Am J Kidney Dis; 2006 Feb; 47(2):251-62. PubMed ID: 16431254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of testosterone supplementation in the aging male.
    Tenover JS
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1092-8. PubMed ID: 1400877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men--a clinical research center study.
    Brodsky IG; Balagopal P; Nair KS
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3469-75. PubMed ID: 8855787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of selective testosterone and estradiol withdrawal on skeletal sensitivity to parathyroid hormone in men.
    Lee H; Finkelstein JS; Miller M; Comeaux SJ; Cohen RI; Leder BZ
    J Clin Endocrinol Metab; 2006 Mar; 91(3):1069-75. PubMed ID: 16352679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.